Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)

GuruFocus.com04-25

On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd (NYSE:BHVN), purchased 25,503 shares of the company, as reported in a recent SEC Filing. This transaction has expanded the insider's ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2430211238?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PlNq3QCKIQ4kIWuX71B49w--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/116e1752398f2e05ec79b7bf6240c127","is_english":true,"pubTime":"2024-04-25 23:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2430211238","market":"us","top_or_hot":-1,"title":"Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)","media":"GuruFocus.com","content":"<div>\n<p>On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd (NYSE:BHVN), purchased 25,503 shares of the company, as reported in a recent SEC Filing. This transaction has expanded the insider's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/director-gregory-bailey-acquires-25-150045299.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDirector Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-25 23:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/director-gregory-bailey-acquires-25-150045299.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd (NYSE:BHVN), purchased 25,503 shares of the company, as reported in a recent SEC Filing. This transaction has expanded the insider's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/director-gregory-bailey-acquires-25-150045299.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BHVN","symbol_name":"Biohaven Pharmaceutical Holding Co Ltd.","start_time":0,"source_url":"https://finance.yahoo.com/news/director-gregory-bailey-acquires-25-150045299.html","article_id":"2430211238","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PlNq3QCKIQ4kIWuX71B49w--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/116e1752398f2e05ec79b7bf6240c127"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2430211238","pubTimestamp":1714057245,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd , purchased 25,503 shares of the company, as reported in a recent SEC Filing. This transaction has expanded the insider's holdings in the company, contributing to a year-long pattern of insider acquisitions.GuruFocus has detected 1 Warning Sign with BHVN.Biohaven Ltd is a biopharmaceutical company engaged in the development and commercialization of novel treatments for neurological diseases, including rare disorders. The company's focus on innovative therapies has positioned it as a notable player in the biotech industry.Over the past year, Gregory Bailey has been an active buyer of Biohaven Ltd stock, with a total of 92,100 shares purchased and no shares sold. This latest acquisition is a continuation of the insider's investment in the company.At the time of the insider's recent purchase, shares of Biohaven Ltd were trading at $39.18 each, valuing the company at a market cap of $3.318 billion.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BHVN":"Biohaven Pharmaceutical Holding Co Ltd.","BK4139":"生物科技","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC"},"translate_title":"Gregory Bailey董事收购Biohaven Ltd(BHVN)25,503股股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHVN":1},"content_text":"On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd (NYSE:BHVN), purchased 25,503 shares of the company, as reported in a recent SEC Filing. This transaction has expanded the insider's holdings in the company, contributing to a year-long pattern of insider acquisitions.\n\nWarning! GuruFocus has detected 1 Warning Sign with BHVN.\n\nBiohaven Ltd is a biopharmaceutical company engaged in the development and commercialization of novel treatments for neurological diseases, including rare disorders. The company's focus on innovative therapies has positioned it as a notable player in the biotech industry.\nOver the past year, Gregory Bailey has been an active buyer of Biohaven Ltd stock, with a total of 92,100 shares purchased and no shares sold. This latest acquisition is a continuation of the insider's investment in the company.\nThe insider transaction history for Biohaven Ltd reveals a trend of more insider buying than selling. There have been 10 insider buys and only 1 insider sell over the past year, indicating a positive sentiment among those with intimate knowledge of the company.\nAt the time of the insider's recent purchase, shares of Biohaven Ltd were trading at $39.18 each, valuing the company at a market cap of $3.318 billion.\n\nInsider buying and selling activities are closely monitored by investors as they can provide insights into a company's internal perspective. Insider buys may suggest that the insiders are confident in the company's future performance and consider the stock undervalued. Conversely, insider sells might indicate that insiders believe the stock is fully valued or they are diversifying their investments.\nInvestors often look for patterns in insider transactions to gauge the potential direction of a stock. The consistent buying pattern of Gregory Bailey and other insiders at Biohaven Ltd could be a signal that those closest to the company foresee positive developments on the horizon.\nThis article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2430211238"}